MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MCRB — Seres Therapeutics, Inc.
NasdaqSeres Therapeutics, Inc.
$2.90
+0.05(+1.75%)
- O
- 2.88
- H
- 3.02
- L
- 2.80
- V
- 76.2K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MCRB
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 26, 2015
Employees66
Stock ExchangeNasdaq
Ticker SymbolMCRB
Key Financial Statistics
| Market Cap | $29.53M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.80 - $29.98 |
| 52-Week Avg Volume | 93.7K |
| VWAP | $2.88 |
| Transactions | 683 |
| Total Recorded Bars | 2,836 days |